ABBOTT LABORATORIES (ABT) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — ABT

Balance Sheet

(in billions USD)

Metric	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	6.80	7.51	6.95	6.53	7.56	6.99	6.28	6.71	7.84	9.16	9.59	8.94	7.68	9.30	8.66	8.05
Short-term Investments	0.49	0.22	0.33	0.31	0.23	0.23	0.37	0.34	0.32	0.37	0.31	0.35	0.48	0.39	0.29	0.32
Accounts Receivable	8.21	8.14	7.97	7.33	7.05	6.85	6.61	6.50	6.17	6.02	6.41	7.20	7.18	6.41	6.11	6.10
Inventory	6.99	6.71	6.95	6.64	6.81	6.81	6.83	6.65	6.87	6.67	5.73	5.90	5.69	5.26	5.44	5.39
Total Current Assets	25.51	24.84	24.47	23.15	23.80	23.12	22.38	22.66	23.51	24.38	24.85	24.96	23.43	23.49	22.63	21.82
Property, Plant & Equipment	12.38	11.50	11.40	10.93	10.62	10.23	10.11	9.55	9.45	9.28	8.69	8.82	8.91	8.83	8.82	8.83
Goodwill	35.22	23.97	23.95	23.36	23.66	23.31	23.38	23.28	23.26	22.93	22.28	22.74	23.18	23.30	23.49	23.38
Intangible Assets	17.88	5.60	5.92	6.26	7.35	7.83	8.30	9.28	9.83	10.01	10.85	11.59	12.23	13.31	13.68	14.18
Total Non-current Assets*	84.92	59.34	59.53	58.30	50.55	49.90	50.09	49.43	49.85	49.42	47.96	49.25	50.58	50.30	50.64	50.97
Total Assets	110.43	84.18	84.00	81.45	74.36	73.02	72.47	72.09	73.35	73.79	72.80	74.20	74.01	73.80	73.27	72.79
Short-term Debt	--	--	--	--	--	--	--	--	--	--	--	--	--	0.20	0.20	0.20
Total Current Liabilities	18.38	14.58	13.44	13.00	14.90	13.76	14.02	13.04	14.35	14.53	13.37	12.39	12.65	12.87	12.61	12.46
Long-term Debt	29.64	11.60	12.93	12.74	12.83	13.14	12.58	14.48	14.56	14.62	15.30	16.76	17.09	17.45	17.55	17.49
Total Non-current Liabilities*	39.99	18.65	20.00	19.63	19.66	19.94	19.64	21.57	21.83	22.25	23.76	25.32	25.96	26.51	26.86	26.76
Total Liabilities*	58.37	33.23	33.43	32.64	34.56	33.70	33.66	34.61	36.18	36.78	37.13	37.71	38.61	39.37	39.47	39.22
Retained Earnings	49.96	49.10	48.47	47.72	39.06	38.35	38.01	36.92	36.35	35.87	35.12	34.49	33.30	30.38	29.05	28.67
Total Stockholder Equity	52.06	50.95	50.57	48.81	39.80	39.32	38.81	37.48	37.17	37.01	35.67	36.49	35.40	34.42	33.80	33.56

* Derived from reported values

Income Statement

(in billions USD) (except per-share rows)

Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Total Revenue	11.16	11.46	11.37	11.14	10.36	10.97	10.64	10.38	9.96	10.24	10.14	9.98	9.75	10.09	10.41	11.26	11.90	11.47	10.93	10.22
Cost of Revenue	4.89	4.92	5.08	4.85	4.47	4.94	4.70	4.60	4.46	4.56	4.61	4.48	4.33	4.59	4.63	4.93	4.99	4.77	4.42	4.95
Gross Profit*	6.27	6.54	6.29	6.29	5.89	6.03	5.94	5.77	5.50	5.69	5.54	5.50	5.42	5.50	5.78	6.32	6.91	6.70	6.51	5.28
Research & Development	0.77	0.74	0.77	0.73	0.72	0.75	0.71	0.70	0.68	0.70	0.67	0.72	0.65	0.73	0.78	0.68	0.70	0.76	0.67	0.65
Selling, General & Admin	3.74	3.13	3.05	3.09	3.06	2.91	2.90	2.94	2.96	2.72	2.72	2.74	2.76	2.97	2.73	2.76	2.79	3.05	2.77	2.73
Total Operating Expenses*	4.93	4.29	4.24	4.24	4.20	4.12	4.08	4.11	4.12	3.91	3.89	3.95	3.91	4.19	4.01	3.95	4.00	4.32	3.96	3.88
Operating Income	1.35	2.25	2.06	2.05	1.69	1.91	1.86	1.67	1.39	1.78	1.65	1.54	1.51	1.30	1.77	2.38	2.91	2.38	2.55	1.39
Interest Expense	--	--	--	--	--	--	--	--	0.14	0.16	0.17	0.16	0.15	0.15	0.14	0.13	0.13	0.13	0.13	0.13
Pretax Income	1.45	2.36	2.18	2.15	1.78	2.03	1.94	1.61	1.44	1.80	1.67	1.64	1.56	1.32	1.76	2.35	2.88	2.33	2.49	1.35
Tax Provision	0.37	0.58	0.54	0.37	0.45	(7.20)	0.29	0.31	0.21	0.20	0.24	0.26	0.24	0.29	0.32	0.33	0.43	0.34	0.39	0.16
Net Income	1.08	1.78	1.64	1.78	1.33	9.23	1.65	1.30	1.23	1.59	1.44	1.38	1.32	1.03	1.44	2.02	2.45	1.99	2.10	1.19
Basic EPS	0.62	1.01	0.94	1.02	0.76	5.29	0.94	0.74	0.70	0.92	0.82	0.79	0.75	0.59	0.82	1.15	1.38	1.12	1.18	0.67
Diluted EPS	0.61	1.01	0.94	1.01	0.76	5.26	0.94	0.74	0.70	0.91	0.82	0.78	0.75	0.59	0.81	1.14	1.37	1.11	1.17	0.66

* Derived from reported values

Cash Flow Statement

(in billions USD)

Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Operating Cash Flow	1.32	3.32	2.79	2.05	1.42	2.87	2.71	1.96	1.02	3.04	1.88	1.20	1.14	2.33	2.78	2.41	2.07	3.07	2.70	2.13
Capital Expenditures	0.40	0.69	0.50	0.50	0.48	0.72	0.56	0.53	0.40	0.76	0.56	0.51	0.38	0.61	0.47	0.38	0.32	0.61	0.46	0.41
Free Cash Flow*	0.92	2.63	2.29	1.55	0.93	2.15	2.15	1.43	0.63	2.28	1.32	0.70	0.76	1.72	2.31	2.03	1.74	2.45	2.24	1.72
Investing Cash Flow	(20.32)	(0.91)	(0.46)	(0.58)	(0.47)	(0.87)	(0.59)	(0.45)	(0.42)	(0.82)	(0.63)	(1.21)	(0.46)	(0.63)	(0.48)	(0.26)	(0.36)	(0.67)	(0.65)	(0.26)
Financing Cash Flow	17.31	(1.40)	(1.76)	(1.10)	(2.06)	(1.86)	(1.58)	(0.79)	(1.18)	(2.05)	(2.34)	(1.29)	(1.41)	(1.46)	(1.54)	(0.81)	(3.82)	(1.89)	(1.38)	(1.26)

* Derived from reported values

Dividends Per Share

(USD)

Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q1 2020	Q3 2018	Q2 2018	Q1 2018	Q3 2017	Q2 2017	Q1 2017	Q3 2016	Q2 2016	Q1 2016	Q3 2015	Q2 2015	Q1 2015
Dividends Per Share	0.63	0.63	0.59	0.55	0.59	0.59	0.51	0.32	0.28	0.28	0.28	0.27	0.27	0.27	0.26	0.26	0.26	0.24	0.24	0.24